Victor Velculescu
#46,720
Most Influential Person Now
Cancer genomics researcher
Victor Velculescu's AcademicInfluence.com Rankings
Victor Velculesculaw Degrees
Law
#1349
World Rank
#1707
Historical Rank
Common Law
#25
World Rank
#28
Historical Rank
Victor Velculescubiology Degrees
Biology
#2567
World Rank
#4046
Historical Rank
Computational Biology
#38
World Rank
#38
Historical Rank
Download Badge
Law Biology
Victor Velculescu's Degrees
- PhD Genetics Johns Hopkins University
Why Is Victor Velculescu Influential?
(Suggest an Edit or Addition)According to Wikipedia, Victor E. Velculescu is a Professor of Oncology and Co-Director of Cancer Biology at Johns Hopkins University School of Medicine. He is internationally known for his discoveries in genomics and cancer research.
Victor Velculescu's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- WAF1, a potential mediator of p53 tumor suppression (1993) (8623)
- Cancer Genome Landscapes (2013) (6203)
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme (2008) (4366)
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (2008) (3758)
- High Frequency of Mutations of the PIK3CA Gene in Human Cancers (2004) (3428)
- IDH1 and IDH2 mutations in gliomas. (2009) (3013)
- The Consensus Coding Sequences of Human Breast and Colorectal Cancers (2006) (2878)
- The Genomic Landscapes of Human Breast and Colorectal Cancers (2007) (2549)
- Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer (2010) (2299)
- Serial Analysis of Gene Expression (1995) (2145)
- WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. (1994) (2076)
- International network of cancer genome projects (2010) (1839)
- Genes expressed in human tumor endothelium. (2000) (1839)
- Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 (2011) (1652)
- DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors (2011) (1474)
- Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status (2002) (1288)
- Neoadjuvant PD‐1 Blockade in Resectable Lung Cancer (2018) (1203)
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal (2013) (1148)
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma (2010) (1123)
- The colorectal microRNAome. (2006) (999)
- Gene expression profiles in normal and cancer cells. (1997) (901)
- Mutant PIK3CA promotes cell growth and invasion of human cancer cells. (2005) (867)
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells (2009) (848)
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene (2009) (788)
- Analysis of human transcriptomes (1999) (783)
- Comparative lesion sequencing provides insights into tumor evolution (2008) (771)
- The Genetic Landscape of the Childhood Cancer Medulloblastoma (2011) (711)
- Direct detection of early-stage cancers using circulating tumor DNA (2017) (703)
- Characterization of the Yeast Transcriptome (1997) (699)
- The PIK3CA gene is mutated with high frequency in human breast cancers (2004) (686)
- A Phosphatase Associated with Metastasis of Colorectal Cancer (2001) (656)
- Using the transcriptome to annotate the genome (2002) (645)
- Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis (2001) (629)
- Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. (1995) (622)
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. (2017) (601)
- Allelic Variation in Human Gene Expression (2002) (591)
- Colorectal cancer: Mutations in a signalling pathway (2005) (578)
- Inactivation of hCDC4 can cause chromosomal instability (2004) (568)
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing (2012) (568)
- Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer. (2013) (560)
- Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas (2013) (555)
- Blood-based analyses of cancer: circulating tumor cells and circulating tumor DNA. (2014) (552)
- Genome-wide cell-free DNA fragmentation in patients with cancer (2019) (541)
- Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers (2004) (533)
- The Antisense Transcriptomes of Human Cells (2008) (526)
- Distinct epigenetic changes in the stromal cells of breast cancers (2005) (505)
- Heteroplasmic mitochondrial DNA mutations in normal and tumor cells (2010) (501)
- Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia (2004) (472)
- A public database for gene expression in human cancers. (1999) (447)
- The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations (2007) (442)
- High grade serous ovarian carcinomas originate in the fallopian tube (2017) (435)
- HEALTH (1979) (434)
- ATM mutations in patients with hereditary pancreatic cancer. (2012) (427)
- Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. (2009) (425)
- Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. (2009) (424)
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing (2010) (410)
- Genetic Progression and the Waiting Time to Cancer (2007) (408)
- Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma (2011) (405)
- Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers (2008) (403)
- Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma (2011) (400)
- Epitope landscape in breast and colorectal cancer. (2008) (396)
- The Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer (2015) (381)
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma (2012) (379)
- Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients (2015) (354)
- Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. (2012) (344)
- Mutations of PIK3CA in Anaplastic Oligodendrogliomas, High-Grade Astrocytomas, and Medulloblastomas (2004) (341)
- Mutational analysis of the tyrosine kinome in colorectal cancers. (2003) (330)
- SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer (2009) (329)
- Sensitive digital quantification of DNA methylation in clinical samples (2009) (319)
- Somatic mutations of EGFR in colorectal cancers and glioblastomas. (2004) (315)
- Personalized genomic analyses for cancer mutation discovery and interpretation (2015) (307)
- Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers (2008) (300)
- Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer (2017) (296)
- Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types (2011) (278)
- Implications of micro-RNA profiling for cancer diagnosis (2006) (269)
- Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer (2011) (262)
- Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) (2018) (241)
- Changes in gene expression associated with developmental arrest and longevity in Caenorhabditis elegans. (2001) (237)
- The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations. (2007) (229)
- Recurrent KRAS codon 146 mutations in human colorectal cancer (2006) (222)
- Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors (2012) (220)
- The Predictive Capacity of Personal Genome Sequencing (2012) (213)
- Analysing uncharted transcriptomes with SAGE. (2000) (212)
- PRL-3 expression in metastatic cancers. (2003) (209)
- Three classes of genes mutated in colorectal cancers with chromosomal instability. (2004) (207)
- Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. (2013) (204)
- Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. (2004) (198)
- Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T (2007) (192)
- Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms (2006) (192)
- Low‐grade serous carcinomas of the ovary contain very few point mutations (2012) (191)
- Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers (2003) (188)
- Biological and clinical importance of the p53 tumor suppressor gene. (1996) (187)
- Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade (2014) (186)
- Prevalence of somatic alterations in the colorectal cancer cell genome (2002) (185)
- Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer (2016) (166)
- Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. (2018) (159)
- Mutant metabolic enzymes are at the origin of gliomas. (2009) (159)
- Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. (2007) (155)
- Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. (2005) (153)
- Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis (2008) (150)
- A multidimensional analysis of genes mutated in breast and colorectal cancers. (2007) (148)
- Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment (2014) (148)
- Genetic Basis of Pancreas Cancer Development and Progression: Insights from Whole-Exome and Whole-Genome Sequencing (2012) (142)
- Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes (2014) (141)
- Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations. (2017) (139)
- Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers (2021) (138)
- The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA (2016) (131)
- Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers (2009) (130)
- Genetic mutations associated with cigarette smoking in pancreatic cancer. (2009) (126)
- Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation (2010) (125)
- The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT (2006) (123)
- Key tumor suppressor genes inactivated by “greater promoter” methylation and somatic mutations in head and neck cancer (2014) (118)
- Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer (2018) (118)
- Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models (2020) (118)
- Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. (2020) (115)
- Identifying markers for pancreatic cancer by gene expression analysis. (1998) (112)
- Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer (2020) (111)
- NORF5/HUG1 Is a Component of theMEC1-Mediated Checkpoint Response to DNA Damage and Replication Arrest in Saccharomyces cerevisiae (1999) (109)
- Identifying tumor origin using a gene expression-based classification map. (2003) (109)
- White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer (2020) (108)
- Mutant PIK 3 CA promotes cell growth and invasion of human cancer cells (2005) (102)
- Precancer Atlas to Drive Precision Prevention Trials. (2017) (98)
- Somatic mutations of PPP2R1A in ovarian and uterine carcinomas. (2011) (88)
- Therapeutic Potential of the Poly(ADP-ribose) Polymerase Inhibitor Rucaparib for the Treatment of Sporadic Human Ovarian Cancer (2013) (87)
- Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics (2016) (87)
- Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers (2006) (87)
- Design and analysis issues in genome-wide somatic mutation studies of cancer. (2009) (87)
- The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity (2018) (87)
- Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer (2019) (84)
- Detection and characterization of lung cancer using cell-free DNA fragmentomes (2021) (83)
- Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade (2019) (82)
- Patient-oriented gene set analysis for cancer mutation data (2010) (79)
- Post-marketing surveillance. (1980) (78)
- Notch1 Mutations Are Drivers of Oral Tumorigenesis (2014) (74)
- Digital karyotyping (2002) (73)
- Oncogenic Mutations of PIK3CA in Human Cancers (2004) (72)
- Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer (2020) (71)
- Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma. (2020) (69)
- Asef , a Link Between the Tumor Suppressor APC and G-Protein Signaling (67)
- Coping with fraud: the Darsee Case. (1983) (67)
- High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets (2019) (66)
- Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non–Small Cell Lung Cancer (2019) (66)
- Defining the blueprint of the cancer genome. (2008) (66)
- A machine learning approach for somatic mutation discovery (2018) (65)
- Drug-resistant TB may bring epidemic (1992) (62)
- Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer. (2019) (61)
- Beyond genomics: critical evaluation of cell line utility for ovarian cancer research. (2015) (61)
- Cancer DNA in the Circulation: The Liquid Biopsy. (2017) (61)
- Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines (2018) (58)
- Sodium ion channel mutations in glioblastoma patients correlate with shorter survival (2011) (58)
- Homozygous deletion of MKK4 in ovarian serous carcinoma (2006) (58)
- Receptor extracellular domains may contain trafficking information. Studies of the 300-kDa mannose 6-phosphate receptor. (1994) (53)
- Personalized Genomic Analyses for Cancer Mutation Discovery and Interpretation. (2015) (52)
- The academic-industrial complex. (1982) (50)
- Perceiving distance accurately by a directional process of integrating ground information (50)
- The microbial plague continues (1997) (48)
- Mutational analysis of gene families in human cancer. (2005) (46)
- Tantalizing Transcriptomes--SAGE and Its Use in Global Gene Expression Analysis (1999) (45)
- Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer Tumors (2016) (44)
- Assessing the benefits. (1980) (43)
- High-throughput gene expression analysis using SAGE (1998) (42)
- WAR , a Potential Mediator of ~ 53 Tumor Suppression (2003) (42)
- Molecular medicine in a changing world (1995) (41)
- Ganitumab (AMG 479) Inhibits IGF-II–Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy (2014) (40)
- Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q (2008) (40)
- Fine-tuning peer review. (1984) (39)
- Extracting Knowledge From Science: A Conversation With Elias Zerhouni (2006) (39)
- Genomic characterization of malignant progression in neoplastic pancreatic cysts (2020) (39)
- A year in the life of biomedical research (1996) (38)
- Gene expression analysis goes digital (2007) (36)
- Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA (2013) (36)
- Neoadjuvant nivolumab in early-stage, resectable non-small cell lung cancers. (2017) (36)
- Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial (2021) (35)
- Osteoporosis reexamined: complexity of bone biology is a challenge. (1987) (35)
- Evaluation of machine learning methods to predict peptide binding to MHC Class I proteins (2017) (35)
- A question of intent. (1989) (35)
- Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma (2020) (34)
- The mystery of the shroud of turin challenges 20th-century science. (1978) (34)
- Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (2019) (33)
- Identification of microbial DNA in human cancer (2009) (32)
- Emerging viruses, emerging threat. (1990) (31)
- Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors (2019) (30)
- Combined MEK and BCL-2/XL Inhibition Is Effective in High-Grade Serous Ovarian Cancer Patient–Derived Xenograft Models and BIM Levels Are Predictive of Responsiveness (2019) (30)
- Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia (2011) (30)
- Psychosurgery: National Commission issues surprisingly favorable report. (1976) (28)
- Sickle cell anemia: national program raises problems as well as hopes. (1972) (27)
- Cancer virus theories: focus of research debate. (1972) (26)
- Sloan-Kettering: The Trials of an Apricot Pit-1973 (1973) (25)
- HeLa Cells: Contaminating Cultures around the World. (1974) (24)
- Neoadjuvant nivolumab plus concurrent chemoradiation in stage II/III esophageal/gastroesophageal junction cancer. (2019) (23)
- Sickle cell anemia: the route from obscurity to prominence. (1972) (22)
- Somatic Mutations in CCK2R Alter Receptor Activity that Promote Oncogenic Phenotypes (2012) (22)
- American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond—Lessons Learned and Member Institutions’ Perspectives (2018) (22)
- The Structure of a Human p 110 a / p 85 a Complex Elucidates the Effects of Oncogenic PI 3 K a Mutations (2007) (22)
- The Dismal State of Scientific Literacy: Studies find only 6% of Americans and 7% of British meet standard for science literacy. (1989) (21)
- Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study (2020) (21)
- Prediction of peptide binding to MHC Class I proteins in the age of deep learning (2017) (21)
- Gene therapy begins. (1990) (20)
- Politics and genes (1995) (20)
- Low-dose radiation. (1979) (20)
- Authorship, data ownership examined. (1988) (18)
- The Structure of a Human p110a/p85a Complex Elucidates the Effects of Oncogenic PI3Ka Mutations (2007) (18)
- Clinical study of genomic drivers in pancreatic ductal adenocarcinoma (2017) (18)
- Essay: Amersham Pharmacia Biotech & Science prize. Tantalizing transcriptomes--SAGE and its use in global gene expression analysis. (1999) (17)
- Fetal research (II): the nature of a Massachusetts law. (1975) (17)
- The Sloan-Kettering Affair: A Story without a Hero. (1974) (17)
- Large-scale identification of novel transcripts in the human genome. (2007) (17)
- Clinical investigation: An endangered science (1995) (16)
- Is Special FDA Regulation Of Nanomedicine Needed? A Conversation With Norris E. Alderson (2008) (16)
- Patients' rights: Harvard is site of battle over X and Y chromosomes. (1974) (16)
- The destroying angel: a story of a search for an antidote. (1974) (16)
- Biomedical research enters the marketplace. (1981) (16)
- Dalkon shield affair: a bad lesson in science and decision-making. (1974) (16)
- XYY: Harvard researcher under fire stops newborn screening. (1975) (16)
- Harvard tackles the rush to publication. (1988) (16)
- Effective expression of small interfering RNA in human cells (15)
- Gene therapy: research in public. (1985) (15)
- Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer. (2016) (15)
- Gore Tex organoids and genetic drugs. (1989) (15)
- Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). (2012) (15)
- Fighting cancer with designer cells (1989) (14)
- NSCLC, early stageNeoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer (2016) (14)
- Abstract NG01: Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer (2017) (14)
- Breast cancer: second thoughts about routine mammography. (1976) (14)
- Take two pets and call me in the morning. (1987) (14)
- Inside the Gallo probe. (1990) (14)
- Let's talk about dying (1996) (14)
- Advances in Brief Activating Mutations of the Noonan Syndrome-Associated SHP 2 / PTPN 11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia (2004) (14)
- Random audit of papers proposed. (1988) (13)
- Penicillin-resistant gonorrhea: new strain spreading worldwide. (1976) (13)
- The Hoechst department of Mass General. (1982) (13)
- Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer (2017) (13)
- Genome‐wide investigation of intragenic DNA methylation identifies ZMIZ1 gene as a prognostic marker in glioblastoma and multiple cancer types (2019) (13)
- Functional synergies yet distinct modulators affected by genetic alterations in common human cancers. (2011) (13)
- Response to Comments on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" (2007) (13)
- Medicine as business: are doctors entrepreneurs? (1986) (13)
- The physician-scientist really is an endangered species. (1998) (13)
- Breast cancer: reports of new therapy are greatly exaggerated. (1976) (13)
- Gene therapy: into the home stretch. (1990) (13)
- Academe and industry debate partnership. (1983) (12)
- The Sloan-Kettering Affair (II): An Uneasy Resolution. (1974) (12)
- Pajaro Dunes: the search for consensus. (1982) (12)
- Amniocentesis: HEW backs test for prenatal diagnosis of disease (1975) (12)
- Recombinant DNA: Cambridge City Council votes moratorium. (1976) (11)
- STATISTICAL METHODS FOR THE ANALYSIS OF CANCER GENOME SEQUENCING DATA (2007) (11)
- 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two (2016) (11)
- Insurers And ‘Targeted Biologics’ For Cancer: A Conversation With Lee N. Newcomer (2008) (11)
- Inherited rare, deleterious variants in ATM increase lung adenocarcinoma risk (2020) (11)
- A bitter battle over error (II) (1988) (11)
- A bitter battle over error. (1988) (11)
- Receptor Extracellular Domains May Contain Trafficking Information (10)
- Mo cell case has its first court hearing. (1984) (10)
- Mapping terra incognita (humani corporis) (1990) (10)
- Harvard researchers retract data in immunology paper. (1986) (10)
- Designing cells to deliver drugs. (1989) (10)
- Cancer detection using whole-genome sequencing of cell free DNA (2013) (10)
- Transcriptome PETs: A genome's best friends (2005) (10)
- Diagnostic strategies towards clinical implementation of liquid biopsy RAS/BRAF circulating tumor DNA analyses in patients with metastatic colorectal cancer. (2020) (9)
- Genetic screening: states may be writing the wrong kind of laws. (1976) (9)
- A conundrum of ethics (1995) (9)
- Kennedy: pushing for more public input in research. (1975) (9)
- Cancer institute unilaterally issues new restrictions on mammography. (1977) (9)
- Acupuncture: Fertile Ground for Faddists and Serious NIH Research. (1972) (9)
- Can reason defeat unreason? (1991) (9)
- Health care economics: the high cost of getting well. (1978) (9)
- National Research Act: restores training, bans fetal research. (1974) (9)
- Save the beaches, not the buildings (1992) (8)
- Gene test begins. (1989) (8)
- Genes and discrimination (1995) (8)
- Harvard and monsanto: the $23-million alliance. (1977) (8)
- Saccharin: a chemical in search of an identity. (1977) (8)
- Emory reports on Darsee's fraud. (1983) (8)
- Science's restive public. (1978) (8)
- Politics of the heart. (1988) (8)
- The Dingell probe finally goes public. (1989) (8)
- Panel backs fetal tissue research. (1988) (7)
- Crash development of AIDS test nears goal. (1984) (7)
- NIH, Inc.: the CRADA boom. (1989) (7)
- Integrity of research papers questioned. (1987) (7)
- AIDS against the rest of the world (1991) (7)
- NIH sees plagiarism in vision paper. (1989) (7)
- Dual publication: "ingelfinger rule" debated by scientists and press. (1972) (7)
- A hero's fight (1991) (7)
- Health manpower act: aid but not comfort for medical schools. (1976) (7)
- Hazards at work. (1980) (7)
- The ideal scientist described. (1990) (7)
- Toxic substances legislation: how well are laws being implemented? (1978) (7)
- Cell membranes: a new look at how they work. (1972) (7)
- Monsanto gives washington u. $ 23.5 million. (1982) (7)
- NIH starts review of training programs. (1984) (6)
- University hospitals for sale. (1984) (6)
- NIH push for women's health (1991) (6)
- Health research feels the chill (1993) (6)
- AZT reverses AIDS dementia in children. (1989) (6)
- High-throughput prediction of MHC Class I and Class II neoantigens with MHCnuggets (2019) (6)
- Eat your broccoli (and brussels sprouts) (1992) (6)
- Hubert Humphrey's bladder cancer (1994) (6)
- US report finds NIH's Gallo guilty of misstatement (1993) (6)
- Science sections in u.s. Newspapers increase dramatically in past 2 years. (1987) (6)
- Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy (2022) (6)
- Medical education under fire. (1984) (6)
- Scientists confront misconduct. (1988) (6)
- Fraud inquiry spreads blame. (1983) (6)
- Breast and Colorectal Cancers The Consensus Coding Sequences of Human (2007) (6)
- Science, society and the press. (1977) (6)
- Robert Gallo forced off NIH stage after HHS vetoes public briefing (1992) (6)
- Gallo inquiry takes puzzling new turn. (1990) (6)
- Grave-robbing: the charge against four from Boston City Hospital. (1974) (6)
- Public participation in science: still in need of definition (1976) (6)
- Legion Fever: "failed" investigation may be successful after all. (1977) (6)
- Ethics advisory board confronts conception in the test tube. (1978) (6)
- National cancer act: deciding on people, policies, and plans. (1972) (6)
- Intensive care for newborns: are there times to pull the plug? (1975) (5)
- Phase 1 trial of gemcitabine/nab-paclitaxel in combination with the autophagy inhibitor hydroxychloroquine in previously untreated patients with metastatic pancreatic adenocarcinoma. (2015) (5)
- Legion Fever: postmortem on an investigation that failed. (1976) (5)
- Gene therapy on the move (1991) (5)
- Flowering of American bioethics. (1978) (5)
- Amplification of the MET receptor to drive resistance to anti-EGFR therapies in colorectal cancer. (2013) (5)
- BRAF Mutations Occur Infrequently in Ovarian Cancer but Suggest Responsiveness to BRAF and MEK Inhibition (2018) (5)
- Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case (review) (1998) (5)
- Dingell v. Baltimore. (1989) (5)
- Studies of myocardial infarction. (1980) (5)
- A genetic shield to prevent emphysema? (1989) (5)
- "Baby Doe" regs thrown out by court. (1983) (5)
- Fetal research (III): the impact of a Massachusetts law. (1975) (5)
- US government orders new look at dioxin (1991) (5)
- Glioblastoma Multiforme An Integrated Genomic Analysis of Human (2010) (5)
- The case of the altered notebooks: Part IV. (1990) (5)
- Gene therapy guidelines revised. (1985) (5)
- How important is early detection? (1977) (5)
- Gene therapy clears first hurdle. (1990) (5)
- The clone ranger. (1978) (5)
- Reverse transcription: one year later. (1971) (5)
- Baltimore cleared of all fraud charges. (1989) (5)
- Mammography Controversy: NIH's Entree into Evaluating Technology. (1977) (4)
- Translating the evolving molecular landscape of tumors to biomarkers of response for cancer immunotherapy (2022) (4)
- Confidentiality: court declares researcher can protect sources. (1976) (4)
- Scientific “experts” and the law (1997) (4)
- The Haemmerli affair: is passive euthanasia murder? (1975) (4)
- KRAS A146 Mutations Are Associated With Distinct Clinical Behavior in Patients With Colorectal Liver Metastases (2021) (4)
- Bok puts computers in their place. (1985) (4)
- Aquaculture: appropriate technology in china. (1979) (4)
- NSF: Defense of Closed Peer Review System Not Persuasive. (1975) (4)
- 'alala live on in Hawaiian forest (1992) (4)
- Widespread PBB Contamination Can Affect Immune System. (1977) (4)
- Disease-of-the-month alive and well (1992) (4)
- Apricot pits and cancer. (1979) (4)
- Drug firm and UC settle interferon suit. (1983) (4)
- Patient sues UCLA over patent on cell line. (1984) (4)
- Scientists dispute book's claim that human clone has been born. (1978) (4)
- Peer Review: OMB May Dismantle NIH Study Sections. (1973) (4)
- TRAB: Testing Whether Mutation Frequencies Are Above an Unknown Background (2008) (4)
- Nanomedicine—The Power Of Proteins: A Conversation With Lance Liotta And Emanual Petricoin (2008) (4)
- Primary care is not the answer (1994) (4)
- Who runs NIH? (1985) (4)
- Hughes Settles with IRS (1987) (4)
- Cooley's Anemia: Special Treatment for Another Ethnic Disease. (1972) (4)
- Cancer: select committee calls virus program a closed shop. (1973) (4)
- Edelin trial: jury not persuaded by scientists for the defense. (1975) (4)
- New biotech review board planned. (1985) (4)
- 333HLA class II Immunogenic Mutation Burden Predicts Response to Immune Checkpoint Blockade. (2022) (4)
- House Battles over NIH Legislation: Representative Waxman's bill is focus of a debate about how much control Congress should have over scientific decisions. (1983) (4)
- Harvard psychiatrist resigns. (1988) (4)
- ADA deficiency: a prime candidate. (1989) (4)
- Symposium on genetics (1979) (3)
- Easier access to clinical trials (1997) (3)
- NIH asked to tighten gene therapy rules. (1986) (3)
- Genetic screening: NAS recommends proceeding with caution. (1975) (3)
- NIH proposes extending life of grants. (1984) (3)
- Wanted: $25 million for mouse house. (1989) (3)
- Whose notes are they? (1989) (3)
- NIH baffled by drop in applications (1994) (3)
- Meanwhile, at NCI the Search for Director Narrows. (1977) (3)
- Monsanto renews ties to washington university. (1990) (3)
- Circulating tumor DNA (ctDNA) as a prognostic marker for recurrence in resected pancreas cancer. (2015) (3)
- For-profit hospitals loom large on health care scene. (1986) (3)
- Gene therapy OK'd. (1988) (3)
- Congress passes NIH bill. (1985) (3)
- NIH readies plan for cost containment. (1990) (3)
- Reagan vetoes NIH bill; override is likely. (1985) (3)
- Clinical labs: bills aimed at correcting "massive" problems. (1976) (3)
- Hughes Institute Poised for Growth: The imminent sale of Hughes Aircraft for billions of dollars will make the Hughes Medical Institute an awesome philanthropy. (1985) (3)
- The mysterious virus called "isn't" (1992) (3)
- Endothelial cells to the rescue. (1989) (3)
- The (private) university of NIH? (1988) (3)
- Response to Comments on “The Predictive Capacity of Personal Genome Sequencing” (2012) (3)
- Shaping science policy: what's happening to biomedical research in America (1991) (3)
- Wyngaarden sets policy agenda for NIH. (1983) (3)
- Bill would set fraud guidelines for scientific publications. (1988) (3)
- A nursing institute for NIH? (1983) (3)
- NIH need clear definition of fraud (1991) (3)
- Restoring immunity: marrow and thymus transplants may do it. (1973) (3)
- Fetal research: the case history of a Massachusetts law. (1975) (3)
- Integrative tumor and immune cell multi-omic analyses to predict melanoma response to immune checkpoint blockade. (2020) (3)
- NIH misconduct probes draw legal complaints. (1990) (3)
- Abortion: litmus test for NIH director. (1989) (3)
- Persistent mutation burden drives sustained anti-tumor immune responses (2023) (3)
- A home for the mighty mouse (1993) (3)
- Fight over Proposed Saccharin Ban Will Not Be Settled for Months. (1977) (3)
- Automated next-generation profiling of genomic alterations in human cancers (2022) (3)
- Preventive medicine: legislation calls for health education. (1975) (3)
- National research act: restores training, bans fetal research. (1974) (3)
- "Internal audit" a challenge. (1988) (3)
- Physicians sued for failing to give genetic counseling. (1979) (3)
- Detecting Liver Cancer Using Cell-Free DNA Fragmentomes (2022) (3)
- Information as a "cure" for cancer. (1985) (3)
- Abstract CT079: Neoadjuvant PD-1 blockade in resectable lung cancer (2018) (3)
- Abstract 619: Identification of clinically actionable genomic alterations in the tumor and circulation of pancreatic cancer patients (2015) (3)
- NSF: Trying to Cope with Congressional Pressure for Public Participation. (1976) (3)
- A comprehensive noninvasive approach for the stratification of lung cancer patients for targeted therapies. (2015) (3)
- National institutes of health: the politics of taste and smell. (1975) (3)
- Health manpower: the feds are taking over. (2003) (3)
- Needed: Fetal Tissue Research (1992) (3)
- "We're Killing Our World". (1987) (3)
- Califano's five-year health plan. (1979) (2)
- One step closer for gene therapy. (1990) (2)
- Merrell dow stops marketing bendectin. (1983) (2)
- NAS Panel Critical of NIOSH Proposal. (1982) (2)
- NIH panel finds no fraud in Cell paper but cites errors. (1988) (2)
- Keyworth gives first policy speech. (1981) (2)
- Promise of Risk Stratification for Multicancer Screening with Liquid Biopsy Tests (2021) (2)
- NIH to Open Budget Sessions to Public. (1976) (2)
- Congress May Gut Federal Floodplains Policy (1977) (2)
- Office of management and budget: skeptical view of scientific advice. (1974) (2)
- Ethics in science. Representative Roe rides to the rescue. (1989) (2)
- Circulating tumor DNA dynamics in resectable gastric cancer. (2018) (2)
- NIH gaining in grants battle. (1985) (2)
- Peer Review: Edwards Denies System Will Be Undone (1973) (2)
- Penicillin g: suddenly a shortage. (1976) (2)
- Discoveries: an innovative platform for publishing cutting-edge research discoveries in medicine, biology and chemistry (2013) (2)
- OMB directive will cost NIH loss of 1500 grants. (1985) (2)
- Science budget squeeze and the zero sum game. (1988) (2)
- Five firms with the right stuff. (1984) (2)
- Critics condemn NIH women's study (1993) (2)
- Abortion and manslaughter: a Boston doctor goes on trial. (1975) (2)
- Conflict at the RAC. (1990) (2)
- National cancer plan: the wheel and the issues go round. (1973) (2)
- Dingell: AIDS researcher in conflict. (1990) (2)
- NAS: A Face-lifting for the Proceedings. (1972) (2)
- Continuing Confusion over Love Canal. (1980) (2)
- Academic search for NCI head. (1988) (2)
- When the data are not clear (1997) (2)
- A non-invasive liquid biopsy approach for therapeutic stratification of lung cancer patients. (2015) (2)
- NIH to award 2200 new grants. (1985) (2)
- Promoting Medical Innovation While Developing Sound Social And Business Policy: A Conversation With Thomas G. Roberts (2008) (2)
- A Conversation with D. Allan Bromley: The President's science adviser is determined to bring science and technology into a broad range of national policy issues. (1989) (2)
- CDC Finds No Excess Illness at Love Canal (1983) (2)
- Four medical schools draw the line on capitation. (1977) (2)
- Perpich to head new Hughes program. (1987) (2)
- Recombinant DNA bills derailed: Congress still trying to pass a law. (1978) (2)
- Kennedy hearings: year-long probe of biomedical research begins. (1976) (2)
- FAS Attacks Politicization of NIH. (1975) (2)
- Fire devastates Jackson lab. (1989) (2)
- "Friends" dance for Library of Medicine. (1986) (2)
- White House wants fetal research ban. (1988) (2)
- Early detection of lung cancer using cfDNA fragmentation. (2021) (2)
- Reviewing peer review (1996) (2)
- Will Employer-Sponsored Health Insurance Endure? (2006) (2)
- Biologics Division To Be Transferred from NIH to FDA. (1972) (2)
- Darsee apologizes to New England Journal. (1983) (2)
- The greatest threat of all (1995) (2)
- OMB raid on NIH budget called "outrageous". (1985) (2)
- Penicillin‐Resistant Gonorrhea: New Strain Spreading Worldwide. (1977) (2)
- Delaney Clause: Defended against an Uncertain Threat of Change. (1973) (2)
- US Government pays hospitals not to train doctors… (1997) (2)
- Material for The Antisense Transcriptomes of Human Cells (2008) (2)
- NIH Advisory Committees: The Politics of Filling Vacancies (1975) (2)
- P2.04-24 Transcriptional Profiling of Neoantigen Specific T Cells in Resectable NSCLC Treated with Neoadjuvant Anti-PD-1 (2019) (2)
- Immunology: two immune systems capture attention. (1973) (2)
- Fredrickson To Be VP of Hughes Institute. (1983) (2)
- NIH begins year-long 100th birthday party. (1986) (2)
- Rising health–care costs inevitable (1995) (2)
- Gore proposes oversight of genetic engineering. (1982) (2)
- Virus cancer program: review panel stands by criticism. (1974) (2)
- Fetal research: ethics commission votes to end the moratorium. (1975) (2)
- AIDS — a treatable disease at last (1996) (2)
- China's "Four Modernizations" Lead to Closer Sino--U.S. Science Ties. (1978) (2)
- Capnocytophaga canimorsus (DF-2) Infection: A Continuing Challenge for Clinicians and Microbiologists* (1999) (2)
- Gene transfer test: so far, so good. (1989) (2)
- Understanding the Enemy (2011) (2)
- Drug resistance growing worse. (1976) (2)
- Genome-wide cell-free DNA fragmentation profiling for early cancer detection. (2019) (2)
- “Innovation” in AIDS vaccines (1997) (2)
- Science Adviser Gets First Formal Look: Yale physicist D. Allan Bromley, in line to head the White House science office, is expected to sail through his confirmation hearings in the Senate scheduled for this week. (1989) (2)
- Wyngaarden to leave NIH. (1989) (2)
- Daniel Zagury cleared of misconduct charges (1992) (2)
- Biomedical research 1973: cancer, heart disease, and everything else. (1973) (2)
- Biomedical funding: the eternal "crisis". (1990) (2)
- Stanford, claiming censorship, sues NIH. (1990) (2)
- AAMC speaks on coping with fraud. (1982) (2)
- Cetus's costly stumble on IL-2. (1990) (2)
- War on cancer--interferon. (1979) (2)
- The jackson laboratory: "mice are our most important product". (1972) (2)
- Stanford doctors try Consulting Inc. (1982) (2)
- Doctor, are you there? (2000) (2)
- NIH to review Emory in Darsee case. (1983) (2)
- Prescription Drugs: HEW Will Only Pay Lowest Price. (1974) (2)
- Medical education: institute puts a price on doctors' heads. (1974) (2)
- Stanford president calls for new authorship policy. (1985) (1)
- OSI finds Popovic guilty on Science paper (1992) (1)
- Gene therapy proposed. (1990) (1)
- NIH pays a price for "stability". (1983) (1)
- New curriculum at Harvard Medical School. (1985) (1)
- The Power Of Dialogue: Medical Innovation And Health Policy (2008) (1)
- It could have been worse for R & D in Carter's "austerity" budget. (1979) (1)
- Healy: In or out at NIH? (1993) (1)
- NIH director: the final lap? (1990) (1)
- Optimistic, independent, aggressive: Texas shoots for the top in science (1992) (1)
- NIH report vindicates Gallo on conduct of AIDS research (1992) (1)
- Fredrickson resigns for NIH. (1981) (1)
- Scientists and the public interest. (1973) (1)
- Science and secrecy. (1983) (1)
- FDA: Review Panel Faults Commissioner's Defense of Agency. (1976) (1)
- Pressure to cut the deficit creates uncertainty for biomedical research. (1986) (1)
- NAS: Academy Votes NRC Changes, New Formula on Classified Research. (1972) (1)
- Choppin takes reins at Howard Hughes. (1987) (1)
- New york mayor honors scientists. (1985) (1)
- Comprehensive modeling of longitudinal circulating tumor DNA dynamics to predict clinical response to first-line immunotherapy and chemoimmunotherapy in advanced non-small cell lung cancer. (2020) (1)
- Ford's Farewell Budget: Science Fares Quite Well. (1977) (1)
- Manslaughter: the charge against Edelin of Boston City Hospital. (1974) (1)
- NIH goes "extra mile" on Gallo. (1990) (1)
- China's new birth policy: one baby is enough. (1979) (1)
- Fixing NIH: the 110% solution. (1988) (1)
- Change in fraud review proposed (1992) (1)
- ADA (adenosine deaminase) gene therapy enters the competition (1990) (1)
- Panel completes interviews in "Baltimore case". (1988) (1)
- The world of biomedical research (1996) (1)
- Erratum: The PIK3CA gene is mutated with high frequency in human breast cancers (Cancer Biology and Therapy (2004) 3 (772-775)) (2005) (1)
- Rockefeller braces for Baltimore. (1990) (1)
- Abstract 3271: A machine learning approach for somatic mutation discovery (2018) (1)
- San Antonio fills research park by making offers that scientists cannot refuse (1992) (1)
- Fraud review may be taken from NIH. (1989) (1)
- Connecticut church passes genetics resolution. (1984) (1)
- NIH: Who Is Running the Show-Scientists or Politicians? (1974) (1)
- Contaminated origin of AIDS viruses (1991) (1)
- Chiropractors and the AMA. (1979) (1)
- Handler defends academy elitism. (1976) (1)
- Fredrickson's bitter end at Hughes. (1987) (1)
- Reagan alters makeup of ethics panel. (1982) (1)
- 'Misconduct' definitions still prove elusive (1994) (1)
- Biomedical research: would special presidential advisers help? (1974) (1)
- Tuskegee apology (1997) (1)
- Cancer Advisory Board: Nobody's Rubber Stamp. (1972) (1)
- Dissenters see for-profits as threat to public interest. (1986) (1)
- MA04.11 Neoantigen Targeting and T Cell Reshaping in Resectable NSCLC Patients Treated with Neoadjuvant PD-1 Blockade (2018) (1)
- NIH delays gene transfer experiment (1988) (1)
- Scientific american sale announced--then challenged. (1986) (1)
- Howard Hughes Moves into Science Education: The giant philanthropy is extending its reach with $30 million to colleges; additional millions for postdoc fellowships, IOM, Cold Spring Harbor, and Jackson Laboratory. (1987) (1)
- Petersdorf to head medical colleges. (1986) (1)
- 1971: steptoe promises to protect test-tube baby from publicity--1978 . . (1978) (1)
- Human experimentation. AIDS trials questioned. (1991) (1)
- Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells (2022) (1)
- Fetal research: HEW rules depart from Commission's recommendations (1975) (1)
- Phase Ib study of rapid alternation of sunitinib (SU) and regorafenib (RE) in patients (pts) with advanced gastrointestinal stromal tumor (GIST). (2018) (1)
- NIH: calling all alumni. (1989) (1)
- Christopher fordham named assistant secretary for health. (1977) (1)
- NAE Seeks a Share of the Limelight: The Engineering Academy, with a renewed focus on technology and society, wants a more prominent role in the policy arena. (1983) (1)
- Pan-Cancer assessment of tumor mutational burden using a comprehensive genomic profiling assay. (2018) (1)
- Help wanted: Director, NIH. (1989) (1)
- The hostile takeover of medicine (1995) (1)
- Medical Devices: Should They Be Cleared before Marketing? (1973) (1)
- The MGH-Hoechst Agreement. (1982) (1)
- Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers (2021) (1)
- Bush asks for 13 per cent extra for science (1991) (1)
- Helping the dying die: two Harvard hospitals go public with policies. (1976) (1)
- Genetic analysis of LOH of chromosome 1p, 19q and PIK3CA mutations in oligodendrogliomas (2005) (1)
- FDA to limit drugs in animal feeds. (1977) (1)
- Panel to redesign NIH director's job. (1989) (1)
- Hughes comments on Fredrickson's leave. (1987) (1)
- Science For Life: A Conversation With Nobel Laureate David Baltimore (2006) (1)
- Caspar weinberger: beware of an "all-pervasive" federal government. (1975) (1)
- Fredrickson resigns from Hughes Institute. (1987) (1)
- NIH reopens Baltimore inquiry. (1989) (1)
- NIH Training Grants: Going, Going, Gone? (1973) (1)
- Arthur Canfield Upton: New Director of the NCI. (1977) (1)
- SW medical center, famous and favoured, is thriving (1992) (1)
- Dead Sea Scrolls released to scholars (1991) (1)
- Which patient did Gallo's virus come from? (1990) (1)
- Cancer society takes pro-saccharin stand. (1977) (1)
- University presidents predict harm from uncoordinated deficit reduction policies . . (1986) (1)
- Scientists' rights: academy adopts "affirmation of freedom". (1976) (1)
- Abstract 3887: Genomic analysis identifies drug targetable pathways and predicts immune infiltration in inflammatory breast cancer tumors (2015) (1)
- French Anderson's 20-year crusade. (1989) (1)
- Wanted: normal brains. (1989) (1)
- Illuminating informed consent (1995) (1)
- McLean-AMI Agree on Joint Venture: One of Harvard's principal psychiatric hospitals forms new company with American Medical International. (1986) (1)
- Healy ready to take on NIH (1991) (1)
- NIH seeks a chief, desperately. (1990) (1)
- Peer Review: OMB May Dismantle NIH Study Sections (1973) (1)
- 1669P Monitoring immune checkpoint inhibition in advanced solid tumors using genome-wide cfDNA fragmentomes (2022) (1)
- Laskers back for 1991. (1990) (1)
- "Baby Doe" squad adviser says HHS was insensitive. (1983) (1)
- AMA: graduate medical education plan OK'd, other issues confronted. (1972) (1)
- Genome-wide cell-free DNA fragmentation in patients with cancer (2019) (1)
- Abstract 2405: A method for comprehensive genomic analysis of cell free DNA (2015) (1)
- Training grants: tied up in congress with ethics bills. (1973) (1)
- On the Rôle of Science Academies (1990) (1)
- Déjà vu in AIDS priority fight. (1990) (1)
- Whose Notes Are They?: On day two of the Dingell hearings, Congress heard a proposal to open scientists' personal data books to general scrutiny (1989) (1)
- Howard hughes medical institute: in the reclusive tradition. (1976) (1)
- Abortion: liberal laws do make abortion safer for women. (1975) (1)
- NIH: Should All the Institutes Be One? (1973) (1)
- Yeast researcher rises to top at whitehead. (1990) (1)
- Hughes, GM battle over stock value. (1988) (1)
- Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (2019) (1)
- Abstract LB-102: Landscape analysis of the initial data release from AACR Project GENIE (2017) (1)
- Early shifts in immune cell subsets to predict response to immune checkpoint blockade in non-small cell lung cancer (NSCLC). (2019) (1)
- Integrative Analysis of Checkpoint Blockade Response in Advanced Non-Small Cell Lung Cancer (2022) (1)
- Biomedical training: time for a slowdown. (1976) (1)
- Academy panel could send saccharin the way of cyclamates. (1973) (1)
- Cancer virus: link to disease in man reported again. (1973) (1)
- Hughes names five vice presidents. (1985) (1)
- A method for comprehensive genomic analysis of cell-free DNA. (2015) (1)
- New biology foundation off to a good start. (1983) (1)
- Abstract 2482: Key tumor suppressor genes inactivated by promoter methylation and somatic mutations in head and neck cancer (2014) (1)
- NIH Starts New Grants Program. (1986) (1)
- HHS halts animal experiment. (1985) (1)
- Biomedical Panel: Urging a Move to Bring Cancer Back into the NIH Fold. (1976) (1)
- Nitrites--to ban or not to ban? (1978) (1)
- Congress passes generous NIH budget. An increase above 10 percent spares NIH unpalatable cuts in grants, programs, and payment of indirect costs. (1983) (1)
- Presidential address sets the tone (1991) (1)
- Abstract 2628: Genome-wide sequencing identifiesATMas a pancreatic cancer susceptibility gene (2012) (1)
- NIH seeks reduction in "indirect costs". (1983) (1)
- New biology foundation offers fellowships. (1982) (1)
- Watson fights back. (1985) (1)
- Schweiker Quits HHS, Heckler Named to Post. (1983) (1)
- Exomic sequencing of pancreatic neuroendocrine tumors: Detection of alterations in chromatin remodeling and mTOR pathway genes. (2011) (0)
- Abstract 1974: Clonal and subclonal mutational landscapes in circulating tumor DNA in metastatic colorectal cancer: An exploratory analysis from the phase III PARADIGM study (2020) (0)
- Resource Integrated Genomic , Epig enomic , and Expression Analyses of Ovarian Cancer Cell Lines Graphical (2018) (0)
- Abstract 1588: Liquid biopsy analyses of cell-free circulating tumor DNA as predictive and prognostic biomarker for colorectal cancer patients with metastatic disease (2018) (0)
- Huang Mutations α Effects of Oncogenic PI 3 K Complex Elucidates the α / p 85 α The Structure of a Human p 110 (2013) (0)
- Abstract LB197: An SU2C-Mark Foundation Lung collaborative update: integrative genomics identifies distinct transcriptional states associated with checkpoint blockade resistance (2021) (0)
- EP01.01-003 DELFI-L101: Development of a Blood-Based Assay That Evaluates Cell-Free DNA Fragmentation Patterns to Detect Lung Cancer (2022) (0)
- Abstract 3668: ctDNA and TCR dynamics predict response toimmune checkpoint blockade in non-small cell lung cancer (2018) (0)
- Blueprint of the breast and colorectal cancer genomes (2007) (0)
- Immune checkpoint inhibition in elderly non-small cell lung cancer patients. (2018) (0)
- Abstract 1617: Sex-specific genomic determinants of response to immunotherapy (2021) (0)
- Abstract 3957: Optimized plasma collection procedures for liquid biopsy analyses in cancer (2016) (0)
- Abstract CT068: CASCADE-LUNG: validation of a blood-based assay that evaluates cell-free DNA fragmentation patterns to detect lung cancer (2023) (0)
- Abstract LB-75: Blood-based molecular detection of acquired resistance to anti-EGFR therapies in colorectal cancer patients. (2013) (0)
- Classification Map Identifying Tumor Origin Using a Gene Expression-based Updated Version (2003) (0)
- Abstract 5246: Noninvasive detection of MET gene amplification in the circulation of cancer patients (2015) (0)
- Abstract 5587: Ultra-deep targeted sequencing of cell-free DNA and patient-matched white blood cells for treatment response evaluation in patients with metastatic colorectal cancer (2023) (0)
- Non-unique barcodes in a genotyping assay (2017) (0)
- Modeling cell-free DNA fragment size densities for non-invasive detection of cancer. (2021) (0)
- Natural Language Processing Approaches for Retrieval of Clinically Relevant Genomic Information in Cancer (2022) (0)
- Identification of Somatically Acquired Gene Mutations In the Kineome and Exome In CLL (2010) (0)
- Abstract GMM-036: COMPREHENSIVE GENOMIC, PROTEOMIC, AND EXPERIMENTAL CHARACTERIZATION OF OVARIAN CLEAR CELL CARCINOMA CELL LINES FOR IMPROVED DRUG DEVELOPMENT (2019) (0)
- Signi fi cance of the Genetic Landscape of Pancreatic Cancer and Implications for Identi fi cation of Potential Long-term Survivors (2012) (0)
- Abstract 773: Early detection of ovarian cancer using cell-free DNA fragmentomes (2023) (0)
- Jihye Yun Pathway Mutations in Tumor Cells KRAS Glucose Deprivation Contributes to the Development of (2013) (0)
- Abstract 1065: Comprehensive molecular and experimental characterization of ovarian clear cell carcinoma cell lines forin vivodrug development (2019) (0)
- Leary Patients with Whole-Genome Sequencing Detection of Chromosomal Alterations in the Circulation of Cancer (2012) (0)
- Abstract 4596: Early noninvasive prediction of response to targeted therapy in non-small cell lung cancer (2018) (0)
- Abstract 5159: Towards population-scale screening of human cancer using genome-wide fragmentation profiles of cell-free DNA (2022) (0)
- Abstract 3580: Integrative genomics of checkpoint blockade response in advanced non-small cell lung cancer (2022) (0)
- Abstract 5902: Integrative genomic analysis of checkpoint blockade in lung cancer: A multi-institution SU2C collaborative (2020) (0)
- OA20.02 Neoantigen Targeting in NSCLC Patients with Complete Response to Anti-PD-1 Immunotherapy (2017) (0)
- 521TiP Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer according the trials within cohorts design: The MEDOCC-CrEATE trial (2020) (0)
- Amplification in DNA Copy Numbers as a Mechanism of Acquired Drug Resistance (2006) (0)
- Abstract 5766: Prospective evaluation of cell-free DNA fragmentomes for lung cancer detection (2023) (0)
- Integrated genomics and avatar mouse models for personalized cancer treatment. (2013) (0)
- Abstract 538: Liquid biopsy approaches for determining pathologic response to neoadjuvant immunotherapy in esophageal cancer (2021) (0)
- Cell-free DNA fragmentomes in the diagnostic evaluation of patients with symptoms suggestive of lung cancer. (2023) (0)
- Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study (2020) (0)
- Abstract B232: Preclinical evaluation of AMG479 a fully human insulin‐like growth factor receptor‐1 (IGFR1) antibody in ovarian cancer cells (2009) (0)
- Identifying Markers for Pancreatic Cancer by Gene Expression 1 (2005) (0)
- The Big Data cancer results are reported in Bert (0)
- Abstract LB-246: Detection of circulating tumor DNA in early stage cancers (2017) (0)
- DynamicsofTumorand ImmuneResponsesduring Immune Checkpoint Blockade in Non–Small Cell Lung Cancer (2019) (0)
- OA12.01 Genomic and Immune Cell Landscape of Response to Chemo-Immunotherapy in Malignant Pleural Mesothelioma (2021) (0)
- Short Communication Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma (2009) (0)
- Abstract 1662: Immunogenomic mechanisms of response and resistance to combined radiation and immunotherapy in lung cancer (2021) (0)
- Improved Lung Cancer Detection in Setting of Underutilized CT Screening: Combination of a Lung Cancer Biomarker With Clinical Risk Assessment (2023) (0)
- MA11.10 Peripheral T Cell Repertoire Evolution in Resectable NSCLC Treated with Neoadjuvant PD-1 Blockade (2019) (0)
- Abstract 3468: Immunoproteasome expression and checkpoint blockade response in advanced non-small cell lung cancer (2023) (0)
- Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer. (2023) (0)
- 1497TiP REACTION – a phase Ib pilot study of nivolumab or nivolumab in combination with relatlimab after targeted radiation in patients with advanced esophagogastric cancer (2020) (0)
- Immunogenomic features of pathologic response to neoadjuvant immune checkpoint blockade in esophageal cancer. (2021) (0)
- Abstract B1-62: Bumphunting analysis identifies PAX5 promoter methylation and p53 somatic mutations in genomic instability pathways linked to very poor survival in head and neck cancer (2015) (0)
- Limits to the Human Cancer Genome Project ? (0)
- Integrated next-generation sequencing and patient-derived xenografts to personalized cancer treatment. (2012) (0)
- Abstract 4041: Coupling neoantigen specific T cell clonotypes and their molecular phenotypes at the single cell level in resectable anti-PD-1 treated NSCLC (2019) (0)
- Abstract A027: Analytic validation of a pan-cancer tumor mutational burden assay (2018) (0)
- Abstract PR11: Dual blockade of BRD4 and the ATR/WEE1 pathway exploits ARID1A loss in clear-cell ovarian cancers (2020) (0)
- Event Cancer screening Localized cancer Metastatic cancer Refractory cancer Treatment strategy Early intervention Multiple DNA abnormalities RNA expression and fusion transcripts (2014) (0)
- Abstract 3358: PLCRC-PROVENC3: assessing the prognostic value of post-surgery liquid biopsy cell-free circulating tumor DNA in stage III colon cancer patients (2023) (0)
- Induction nivolumab or nivolumab/ipilimumab prior to concurrent chemoradiation plus nivolumab in patients with operable stage II/III esophageal/gastroesophageal junction cancer. (2018) (0)
- Genomic and Immunological Tumor Pro fi ling Identi fi es Targetable Pathways and Extensive CD 8 þ / PDL 1 þ Immune In fi ltration in In fl ammatory Breast Cancer Tumors (2016) (0)
- Abstract 3366: A machine learning approach to determine the cellular origin of variants in liquid biopsies (2023) (0)
- Abstract 519: Clinical impact ofKRASG12, G13, Q61, K117 and A146 mutations in patients with colorectal liver metastases (2022) (0)
- Abstract 2773: Chronic cigarette smoke exposure of bronchial epithelial cells induces progressive epigenomic changes leading to transformation (2016) (0)
- Abstract 540: Molecular response evaluation of patients with metastatic colorectal cancer using circulating tumor DNA (2021) (0)
- Cancer Therapy : Preclinical Ganitumab ( AMG 479 ) Inhibits IGF-II – Dependent Ovarian Cancer Growth and Potentiates Platinum-Based Chemotherapy (2014) (0)
- Su1148: CHROMATIN ACCESSIBILITY CAN IDENTIFY DISEASE STATE IN PATIENT DERIVED COLONIC ORGANOIDS (2022) (0)
- Abstract PR3: Exome sequencing of head and neck squamous cell carcinoma reveals a higher frequency of mutations in TP53 among African Americans (2011) (0)
- White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer (2020) (0)
- Analysis of Circulating DNA Serial Assessment of Human Tumor Burdens in Mice by the (2007) (0)
- Abstract 1393: Persistent mutation burden drives sustained anti-tumor immune responses in human cancers (2023) (0)
- Potential utility of risk stratification for multicancer screening with liquid biopsy tests (2023) (0)
- Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer. (2023) (0)
- Abstract 27: Early dynamics in peripheral blood immune cell subsets and ctDNA are predictive of outcome to immunotherapy (2021) (0)
- Identifying Markers for Pancreatic Cancer by Gene (2017) (0)
- The intersection of basic science and health policy: a conversation with Victor Velculescu. Interview by Barbara J. Culliton. (2008) (0)
- Mutational analysis of signaling pathways in colorectal cancer (2005) (0)
- Abstract 2224: DELFI as a real-time treatment response assessment for patients with cancer (2022) (0)
- Advances in Brief WAF 1 / CIP 1 Is Induced in / ? 53-mediated G ! Arrest and Apoptosis 1 (2006) (0)
- Abstract 798: Clonal analysis and clinical translation of pancreatic adenocarcinoma genomes. (2013) (0)
- Abstract LB-154: Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small cell lung carcinoma (NSCLC): A proposal for quantitative immune-related pathologic response criteria (irPRC) (2018) (0)
- Corrigendum to "HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade": [Annals of Oncology volume 33 (2022) 728-738]. (2023) (0)
- PIK3CA gene mutations in human cancers (2005) (0)
- Abstract 5714: Cell-free DNA fragmentation profiling for monitoring therapeutic response in metastatic colorectal cancer (2023) (0)
- Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer (2017) (0)
- Abstract 3894: The importance of matched tumor and normal DNA for somatic mutation discovery and clinical interpretation (2015) (0)
- Abstract 570: Detecting cancer using genome-wide cfDNA nucleosomal fragmentation in a prospective multi cancer cohort (2021) (0)
- Series analysis method of gene expression (1996) (0)
- Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1 (Journal for Immuno Therapy of Cancer (2019) 7 (40) DOI: 10.1186/s40425-018-0492-x) (2019) (0)
- Enhancing Diagnostic Evaluation of Patients with Symptoms of Lung Cancer Using the DELFI Circulating Cell-Free DNA Approach for Cancer Detection (2022) (0)
- Abstract 528: Identify and prioritize candidate neoantigens from cancer exome sequencing with unmatched accuracy (2016) (0)
- Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis (2022) (0)
- Abstract 2205: Integrated next generation sequencing and patient-derived xenografts to personalized cancer treatment. (2013) (0)
- Abstract 3278: Identification of epigenetic therapy induced tumor antigens to promote proliferation and infiltration of antigen specific T cells in non-small cell lung cancer (2022) (0)
- High grade serous ovarian carcinomas originate in the fallopian tube (2017) (0)
- Abstract 604: Accurate identification and prioritization of candidate neoantigens from integrated cancer exome and transcriptome sequencing of FFPE samples (2017) (0)
- Abstract 4954: Clinical validation of a cell-free DNA liquid biopsy approach for noninvasive molecular profiling (2017) (0)
- 218 Genomic analysis identifies novel drivers and targetable pathways in inflammatory breast cancer patient samples (2014) (0)
- Genome-wide cfDNA fragmentation in patients with cancer and other diseases. (2021) (0)
- Abstract 3096: Liquid biopsy cell-free circulating tumor DNA as prognostic biomarker for stage III colon cancer patients (2020) (0)
- Abstract CT251: MEDOCC-CrEATE trial in progress: effectiveness of adjuvant chemotherapy in stage II colon cancer patients with positive circulating tumor DNA (2021) (0)
- Abstract 3977: Clinical validation of cell-free circulating tumor DNA to detect therapy resistance and disease progression in metastatic colorectal cancer patients (2019) (0)
- Abstract A039: Accurate identification and prioritization of candidate neoantigens from cancer exome sequencing (2016) (0)
- Abstract 1668: Longitudinal dynamics of circulating tumor DNA and plasma proteomics predict clinical outcomes to immunotherapy in non-small cell lung cancer (2021) (0)
- Reply to: Limitations of molecular testing in combination with computerized tomographic for lung cancer screening (2022) (0)
- In Reply: NIH Budget Growth (1985) (0)
- Perot to fund scientist-physicians. (1988) (0)
- Conflict at the RAC. (1990) (0)
- Alvin Trivelpiece of DOE Is Named New Executive Officer of AAAS (1987) (0)
- Darsee Apologizes to New England Journal (1983) (0)
- IOM Launches Study of NIH. (1983) (0)
- NIH to Restore Slashed Grants (1987) (0)
- MIT Gets $3 Million for News Fellowships (1987) (0)
- Another congressional look at fraud. (1989) (0)
- Cancer Cure Promised (1974) (0)
- Physicians Sued for Failing to Give Genetic Counseling (1979) (0)
- Charges dropped in haemmerli case in Switzerland. (1976) (0)
- Maxwell may back Gallo. (1987) (0)
- Episcopal Church Backs Genetic Engineering (1985) (0)
- Nobelists back animal research. (1989) (0)
- NIH: Reunion Held to Boost Morale and Gain Political Visibility. (1975) (0)
- APA Issues Warning on Antipsychotic Drugs. (1985) (0)
- Howard Hughes institute offers new grants (1995) (0)
- Cancer researchers defend NCI against congressional attacks. (1981) (0)
- Woods hole: winterizing the marine biological laboratory. (1972) (0)
- Wanted: $25 Million for Mouse House (1989) (0)
- Biomedical leadership: cooper, fredrickson ready to step in. (1975) (0)
- Scientists' Rights: Academy Adopts "Affirmation of Freedom" (1976) (0)
- Clinton courts research hospitals (1994) (0)
- AIDS. Leaked report queries Gallo patent. (1991) (0)
- Cloning caper makes it to the halls of congress. (1978) (0)
- Fredrickson Says Yes . . . (1974) (0)
- Pursuing Medical Progress: Managing Benefits And Risks (2007) (0)
- Scientists hope to generate new research in areas of greatest relevance to human welfare. (2016) (0)
- OMB slashes NIH budget for FY 88. (1986) (0)
- NIH urged to forge new ties to Congress. (1987) (0)
- NIH: Help Wanted (1975) (0)
- Peter Bourne's mistake: a prescription for trouble. (1978) (0)
- Limits of Scientific Inquiry (1979) (0)
- Time Inc. Buys Science Digest (1986) (0)
- Bromley Moves West (1990) (0)
- A venue for progress (1996) (0)
- Keyworth Attacks the Press (1985) (0)
- Foreign Affairs (1990) (0)
- Cancer Board attacks tobacco. (1989) (0)
- Vancouver Votes Against Habitat (1975) (0)
- Lederberg named President of Rockefeller University (1978) (0)
- Hughes Comments on Fredrickson's Leave (1987) (0)
- Science in China (1979) (0)
- GM, Hughes settle stock fight. (1989) (0)
- Global Health Care Matters: Broadening The Focus (2007) (0)
- Biomedicine: not exactly a banner year. (1973) (0)
- Tosteson New Harvard Dean: Chicago Bitter About His Leaving (1977) (0)
- NIH wasted millions on computers (1992) (0)
- Hughes expands in the Americas (1997) (0)
- In Reply: Battle Over Error (1988) (0)
- Academy holds open hearing on research training needs. (1976) (0)
- The crisis in biomedical research: real but overstated. (1991) (0)
- Institute of Aging Gets Surprise Veto (1972) (0)
- Finding NIH Institute Directors Is Not Easy to Do (1975) (0)
- How to Win the Nobel Prize: An Unexpected Life in Science (review) (2004) (0)
- Gerald R. Ford, Jimmy Carter: Candidates 1976. (1976) (0)
- An attempt to regulate medical decision making. (1983) (0)
- Gallo and Popovic lawyers reply (1992) (0)
- Carter Revives Dream of a Sea-Level Canal (1977) (0)
- Reagan Endorses NAE's "Decade III" Program. (1985) (0)
- 13. Office Of Management And Budget: Skeptical View Of Scientific Advice (2019) (0)
- Woods hole mulls titanic expedition. (1977) (0)
- Wanted: A few good ideas (1995) (0)
- Cancer Virus Theories: Focus of Research Debate (1972) (0)
- HEW Suggests End of Tobacco Subsidy (1975) (0)
- Science 86 Sold to Time Inc. (1986) (0)
- Biomedical Research (II): Will the "Wars" Ever Get Started? (1973) (0)
- Stone Reportedly New NIH Head (1973) (0)
- If They Held a Meeting There'd Be No One to Come (1977) (0)
- Health Hierarchy: Marston Fired and He's Not the Only One. (1972) (0)
- Rival Boston hospitals set to merge (1993) (0)
- Fight over Proposed Saccharin Ban Will Not Be Settled for Months (1977) (0)
- Reagan Endorses NAE's "Decade III" Program (1985) (0)
- Carter going slow on national health insurance. (1977) (0)
- Jim Watson on the budget. (1988) (0)
- NY hospitals win education subsidy (1997) (0)
- David Packard Tackles OMB on Indirect Costs (1986) (0)
- Harvard acknowledges it could have done better. (1983) (0)
- DuVal: giving the job of "top doctor" some substance. (1972) (0)
- NCI Director Resigns Because Congress Blocked Pay Raise. (1976) (0)
- Danforth Reapproached (1990) (0)
- Congress, NIH dedicate center to Mary Lasker. (1984) (0)
- Back at NIH, Marston's Firing Prompts Mild Protest (1973) (0)
- "I am not a neat person". (1989) (0)
- Carnegie Launches Education Forum: A long-term look at science education policy and the economy is intended to sustain current interest in education issues. (1985) (0)
- Dingell disavows ‘Dingell’ report on Gallo (1995) (0)
- Alexander Bearn: new Hughes trustee. (1987) (0)
- U.s. Refuses to back soviets on dissidents and psychiatry. (1977) (0)
- Photocopying habit in jeopardy. (1972) (0)
- Gerald R. Ford. (1976) (0)
- First "Right-to-Die" Law Passes. (1976) (0)
- Yeast Researcher Rises to Top at Whitehead (1990) (0)
- Training Grants (I): There Is Hope Some May Be Salvaged (1973) (0)
- Science Wins Olive Branch (1987) (0)
- Mental health research will return to NIH (1991) (0)
- Biomedical panel: report says the enterprise is basically sound. (1976) (0)
- NIH dedicates museum to DeWitt Stetten. (1987) (0)
- Minnesota Gets Institute for Theoretical Physics (1987) (0)
- Response : The Sloan-Kettering Affair (1974) (0)
- Frank press calls budget summit. (1981) (0)
- The Intersection Of Basic Science And Health Policy: A Conversation With Victor Velculescu (2008) (0)
- The Struggle That Never Ends: Reforming U.S. Health Care (2005) (0)
- Clinical researchers, by the book (1995) (0)
- Grant termination: scientist wins $16 million for loss of support. (1972) (0)
- Omnibus health bill: vaccines, drug exports, physician peer review. (1986) (0)
- The Rocky Road to Remission (1989) (0)
- Biomedical delegation lobbies white house. (1985) (0)
- Bush goes 0 for 2 with Anthony Fauci. (1989) (0)
- Kennedy suggests NIH foundation. (1988) (0)
- COMINGS AND GOINGS (1987) (0)
- Reinventing clinical investigation (1995) (0)
- Ames Named Director of N.Y. Academy (1989) (0)
- Stringent new ethics law worries government scientists. (1979) (0)
- Frazier honored by psychiatrists. (1989) (0)
- Recollections on the war on cancer. (1987) (0)
- Merrell Dow Stops Marketing Bendectin (1983) (0)
- Firing of NIMH Head Brown Holds No Portent for NIH. (1978) (0)
- Assessing the State of Cancer Research (1971) (0)
- New Biology Foundation Off to a Good Start (1983) (0)
- CRADAs Raise Conflict Issues. (1989) (0)
- Institutes proposed for deafness, rehabilitation. (1988) (0)
- Biotechnology and God (1995) (0)
- Antiabortionists Challenge March of Dimes (1975) (0)
- President awards science medals. (1976) (0)
- There's a xeno in your future (1995) (0)
- Principal health manpower provisions. (1976) (0)
- Clark of NSF to Be V.P. of Bowling Green. (1983) (0)
- It's Not Over Yet (1989) (0)
- Lederberg new president of rockefeller university. (1978) (0)
- Budget boost for science (1991) (0)
- NIH Institute Directors: One Gain, One Loss (1975) (0)
- Christopher Fordham Named Assistant Secretary for Health (1977) (0)
- David Packard Tackles OMB on Indirect Costs. (1986) (0)
- Bush salutes NIH at Healy's swearing-in (1991) (0)
- Leaked report queries Gallo patent (1991) (0)
- AIDS research. French minister clears Zagury. (1991) (0)
- Bok Puts Computers in Their Place (1985) (0)
- Public relations: a federal focus on health. (1973) (0)
- Donald Kennedy to Head FDA (1977) (0)
- AIDS drugs remain unavailable for kids. (1989) (0)
- FDA panel backs interleukin-2. (1992) (0)
- AAU's Poem to Itself. (1986) (0)
- AAU Praises New Version of A-21 Rules. (1986) (0)
- Drug agency's research fails to make the grade (1997) (0)
- Bush Hails Science at NAS (1990) (0)
- Schmitt to Seek Commission on All Hazardous Research (1978) (0)
- March of Dimes Denies Giving In to Antiabortionists (1978) (0)
- Fetal research morally "acceptable". (1988) (0)
- Institute of medicine: taking on study of cost of medical education. (1972) (0)
- President carter addresses national academy. (1979) (0)
- Cancer Board Appointees Strong in Science (1984) (0)
- Harvard Under Fire for Mishandling Grant Money (1977) (0)
- NIH labours to maintain excellence despite tight budget and staffing (1992) (0)
- Scientifically Speaking: Old Turks and Young Turks (1980) (0)
- Biomedical Delegation Lobbies White House (1985) (0)
- AMA: Specialty Journals Must Lure Paying Subscribers. (1972) (0)
- Training Grants (II): Remedy Sought by Persuasion and by Legislation. (1973) (0)
- FDA gets Kessler; NIH gets left out. (1990) (0)
- Will Russell Peterson Be OTA's New Direction? (1977) (0)
- NIH to Use Forensics (1989) (0)
- AMA: Major Issues Draw Only Moderate Debate. (1973) (0)
- NIH: Cancer Institute Politics Complicate a Difficult Case. (1976) (0)
- Johnson health policy fellows: joining the scientific and political. (1975) (0)
- March of dimes denies giving in to antiabortionists. (1978) (0)
- Scientific American Sale Announced—Then Challenged (1986) (0)
- Hammer seeks $1 billion to cure cancer. (1988) (0)
- Frank Press To Be Nominated for NAS. (1980) (0)
- Birth control: report argues new leads are neglected. (1976) (0)
- IOM Launches Study of NIH (1983) (0)
- Grave-Robbing: The Charge against Four from Boston City Hospital. (1974) (0)
- Errors in cell paper acknowledged. (1988) (0)
- Fraudbusters back at NIH. (1990) (0)
- Carter's Budget: Little Biomedical Growth; Energy Conservation Pushed (1977) (0)
- Frazier reinstated at McLean. (1989) (0)
- Woods Hole Mulls Titanic Expedition (1977) (0)
- Choppin Is New Head of Howard Hughes (1987) (0)
- Califano takes richmond. (1977) (0)
- Behavioural medicine. Mental health research will return to NIH. (1991) (0)
- NCI Director Set to Leave. (1976) (0)
- New York Mayor Honors Scientists (1985) (0)
- AAU's Poem to Itself (1986) (0)
- Geneticists boycott moscow congress. (1978) (0)
- GAO report angers cancer officials. (1987) (0)
- Schmitt to seek commission on all hazardous research. (1978) (0)
- Habitat: U.N. Conference to Face Crises in Human Settlements (1975) (0)
- Misconduct charges against Gallo withdrawn after Popovic decision (1993) (0)
- Scientific American Sale to German Publisher Okayed (1986) (0)
- Keyworth attacks the press. (1985) (0)
- NCI's Retrospective Look at Laetrile Seems Doomed to Fail. (1978) (0)
- NIH: the endless search. (1990) (0)
- Schweiker Quits HHS, Heckler Named to Post (1983) (0)
- AAU Praises New Version of A-21 Rules (1986) (0)
- NCI Director Resigns Because Congress Blocked Pay Raise (1976) (0)
- Burroughs Wellcome Fund throws lifeline to endangered clinical science (1997) (0)
- Advances on the flu front. (1980) (0)
- Moderation in all things (1996) (0)
- Berliner resigns from NIH. (1973) (0)
- Demise of Military Med School Likely (1977) (0)
- NIH to Use Forensics. (1989) (0)
- Carter OK Needed for NCI Job (1977) (0)
- Turks meeting on boardwalk: debate on role in political arena. (1972) (0)
- "We're Killing Our World" (1987) (0)
- Shroud shrouded in biofilm (1995) (0)
- The recommendations. (1977) (0)
- Tosteson new harvard dean: chicago bitter about his leaving. (1977) (0)
- AIDS amendment angers cancer institute. (1984) (0)
- Califano Praises NIH, Retains Fredrickson as Director. (1977) (0)
- Numbers game fuels debate on international health priorities (1997) (0)
- Bush Hails Science at NAS. (1990) (0)
- Cancer Society Takes Pro-Saccharin Stand (1977) (0)
- Katchalsky killed in tel aviv. (1972) (0)
- Congress Reports on Gene Therapy (1984) (0)
- NIH: The Good Old Days (1989) (0)
- AAAS meeting. Presidential address sets the tone. (1991) (0)
- Yale to cut departments (1992) (0)
- Charges Dropped in Haemmerli Case in Switzerland (1976) (0)
- Congress may gut federal floodplains policy. (1977) (0)
- Congress boosts NIH budget 17.3%. (1986) (0)
- Scientists probe Russian viruses. (1973) (0)
- NIH Budget on the Decline. (1977) (0)
- Viruses across the sea. (1984) (0)
- California Ballot (1986) (0)
- Adverse drug reactions: monitoring needed of drugs on market. (1977) (0)
- More on death and dying (1996) (0)
- The OSI on Crewdson on Gallo (1992) (0)
- Wyngaarden Meets the Press (1982) (0)
- States Debate Death with Dignity Bills (1975) (0)
- IOM names committee to study NIH. (1988) (0)
- Fisher settles with the University of Pittsburgh and the NCI (1997) (0)
- NAS Hopes to Save Issues (1987) (0)
- NIH considers major change in definition of recombinant DNA. (1986) (0)
- Klausner at NCI (1995) (0)
- Samuel Broder new head of NCI. (1989) (0)
- Deal struck on NIH grants. (1985) (0)
- Howard Hughes establishes unit at MIT. (1988) (0)
- Study of NIH Gets Under Way: The biomedical research community is feeling hard-pressed to defend the traditional organization of basic research against the demands of special interest groups and their congressional supporters. (1983) (0)
- It matters how you slice the pie. (1988) (0)
- The story so far--chronology, dramatis personae. (1989) (0)
- Imanishi–Kari finally gets appeal (1995) (0)
- NIH director Stone: another manager on Nixon's health team. (1973) (0)
- Fredrickson takes leave from hughes. (1987) (0)
- Baltimore to succeed Lederberg? (1989) (0)
- Hughes Institute spreads the wealth. (1988) (0)
- Cancer board appointees strong in science. (1984) (0)
- American Tentative Society Has Money, Needs Ideas (1974) (0)
- Place in Sun for Marston, Downtown for Sherman (1974) (0)
- Hughes Names Five Vice Presidents (1985) (0)
- Clark of NSF to Be V.P. of Bowling Green (1983) (0)
- Hughes Makes Awards to University Science (1989) (0)
- Mosher sues stanford. (1986) (0)
- Popovic wins appeal against ORI charges (1993) (0)
- Press Calls for End of Special Lobbying (1985) (0)
- Edelin Case Will Go to Trial (1974) (0)
- Science 86 sold to time inc. (1986) (0)
- AIDS trials questioned (1991) (0)
- Alvin Trivelpiece of DOE Is Named New Executive Officer of AAAS. (1987) (0)
- New twist in the long saga of HIV (1991) (0)
- Biomedical research budget drops again. (1975) (0)
- Biomedical Panel: Report Says the Enterprise Is Basically Sound (1976) (0)
- Changes in ethics act benefit scientists. (1979) (0)
- China to build synchrotron near the ming tombs. (1979) (0)
- Frank press in line for academy presidency. (1980) (0)
- Stanford psychiatry deal falls through. (1990) (0)
- Law Sets Study of Biomedical Research (1974) (0)
- Rockefeller braces for Baltimore. (1990) (0)
- Senate Bill Would Redo Commission (1975) (0)
- APA Issues Warning on Antipsychotic Drugs (1985) (0)
- Carter on Continuous Creation ...... Regan on Intermittent Astrology (1980) (0)
- Inter v iew Is Special FDA Regulation Of Nanomedicine Needed? A Conversation With Norris E. Alderson At this point, the FDA evaluates nanoparticles as it does all other areas under its purview: for safety and efficacy in patients. (2008) (0)
- Varmus deft with Senate on NIH strategy (1993) (0)
- The bottom line (1997) (0)
- Ahead of the Curve: David Baltimore's Life in Science (review) (2003) (0)
- Managed care & conflict of interest (1996) (0)
- Mosher Sues Stanford (1986) (0)
- First "Right-to-Die" Law Passes (1976) (0)
- Rosenberg Says No CRADA (1989) (0)
- Carter Says No to Cooper; Fredrickson's Future Unsure. (1977) (0)
- Leaning over Backwards on a No-Politics Rule. (1978) (0)
- The Committees (1990) (0)
- Superpay for NIH superstars. (1989) (0)
- Cooper Leaves Heart Institute for HEW (1974) (0)
- OSTP Pursues Use of Existing Laws. (1978) (0)
- Panel backs fetal tissue research. (1988) (0)
- Kean v. AAAS Settled Out of Court (1981) (0)
- If They Held a Meeting There'd Be No One to Come. (1977) (0)
- Stetten Science Deputy at NIH (1974) (0)
- NIH role in biotechnology debated. (1985) (0)
- Journals and data disclosure (1988) (0)
- Biomedical Leadership and the Waiting Game (1975) (0)
- Credit for Whistle-Blower Vanishes (1989) (0)
- A Decade of Discussion (1990) (0)
- Time Inc. Buys Science Digest (1986) (0)
- MIT Scientist to Head FDA's Bureau of Foods (1978) (0)
- Mit gets $3 million for news fellowships. (1987) (0)
- Lasker Foundation Suspends 1990 Awards (1990) (0)
- Expect more from embryos (1996) (0)
- New Vice President and Trustee Named at Hughes (1987) (0)
- President Ford at NIH: Courting Biomedical Science. (1975) (0)
- Fetal Research Morally "Acceptable" (1988) (0)
- Second opinion on surgery. (1979) (0)
- New Biology Foundation Offers Fellowships (1982) (0)
- NIH says "yes" to acupuncture. (1997) (0)
- Government Support of Research Queried (1974) (0)
- Cancer news: cancer society makes it with style. (1973) (0)
- Hillary Clinton lobbies at Hopkins for health (1993) (0)
- Another biotech board proposal. (1985) (0)
- Why the Doors Stayed Closed (1982) (0)
- IOM Votes Statement Against Nuclear War. (1982) (0)
- Who is really behind Clinton's AIDS Vaccine crusade? (1997) (0)
- Institute Scrubs Three Committees (1974) (0)
- Carter Orders Environmental Review of U.S. Projects Abroad (1979) (0)
- Loss of specialists hurts research (1996) (0)
- NIH director: sixth time lucky? (1990) (0)
- NAS weighs in with 7-lb diet guide. (1989) (0)
- 19 say no to NIH job. (1989) (0)
- Bush makes some science appointments. (1989) (0)
- NIH: Plan to Charge Research Patients Provokes Protest (1973) (0)
- NIH bills moving through Congress. (1985) (0)
- Proposed terms of sale. (1984) (0)
- NIOSH Backs Down on Portsmouth Study. (1982) (0)
- Watson Fights Back (1985) (0)
- Lederberg New President of Rockefeller University (1978) (0)
- Frank Press in Line for Academy Presidency (1980) (0)
- Fredrickson To Be VP of Hughes Institute (1983) (0)
- Vindication is sweet, but not sufficient (1996) (0)
- Carter OK Needed for NCI Job. (1977) (0)
- The politics of biology: young academicians becoming involved. (1974) (0)
- Carter's Budget: Little Biomedical Growth; Energy Conservation Pushed. (1977) (0)
- Competitiveness for stability (1993) (0)
- Mammography Controversy: NIH's Entrée into Evaluating Technology (1977) (0)
- Edelin conviction overturned. (1977) (0)
- Fire devastates Jackson Lab (1989) (0)
- Person-rems and the future. (1979) (0)
- Gallo reports mystery break-in (1990) (0)
- Wyngaarden meets the press. (1982) (0)
- NIH leaves gene therapy rules as is. (1986) (0)
- Jim Watson on the Budget (1988) (0)
- Laser foundation suspends 1990 awards. (1990) (0)
- A battle over NIH funds. (1987) (0)
- French minister clears Zagury (1991) (0)
- China's New Birth Policy: One Baby Is Enough (1979) (0)
- Senators warn of changing climate for research (1994) (0)
- All Cancer Is Genetic (2013) (0)
- The White House and the Cancer Board (1974) (0)
- Gene test begins. (1989) (0)
- Fraudbusters back at NIH. (1990) (0)
- NIH director: the search goes on ... and on. (1990) (0)
- NIH: Robert Stone Is in Trouble with HEW. (1974) (0)
- Academics in new york and california fight disclosure policies. (1977) (0)
- NAS Hopes to Save Issues. (1987) (0)
- DeVita is Leaving Cancer Institute for Sloan-Kettering (1988) (0)
- Mapping Terra Incognita (Humani Corporis): Since the Renaissance, human anatomy has been mapped in ever finer detail--now the genome project (1990) (0)
- Court rules in patient privacy case. (1985) (0)
- Response : Battle Over Error (1988) (0)
- Califano loses fordham as assistant secretary. (1977) (0)
- MIT Scientist to Head FDA's Bureau of Foods. (1978) (0)
- Court Order Opens (1973) (0)
- Scientific american sale to german publisher okayed. (1986) (0)
- NIH faces $236-million budget cut in FY 1986. (1986) (0)
- Richard S. Nicholson to Head AAAS (1989) (0)
- Prospective Evaluation of cfDNA Fragmentomes for Lung Cancer Detection (2023) (0)
- Epigenetic Profiling and Epigenetic Therapy in Cancer (2008) (0)
This paper list is powered by the following services:
Other Resources About Victor Velculescu
What Schools Are Affiliated With Victor Velculescu?
Victor Velculescu is affiliated with the following schools:
